MSF and DNDi call for scale-up of R&D for neglected diseases
Feb 23 2009
Some 500 million people worldwide are at risk from sleeping sickness, visceral leishmaniasis, and Chagas disease, but those deadly ailments receive less than 5 percent of the global research and development (R&D) funds allocated even to neglected diseases.

To read the MSF press release in English

Neglected Diseases ‘Need Sustainable Funding’
by iwahlstrom

WASHINGTON, Feb 24 ( – Millions of people are suffering and dying needlessly from diseases whose potential treatments don’t promise to turn a profit for drug companies, warned doctors and humanitarian aid workers yesterday.

Click here to read more on oneworld website

Tagged with →  
Share →

Leave a Reply

Your email address will not be published.

Please fill in the below * Time limit is exhausted. Please reload the CAPTCHA.

Set your Twitter account name in your settings to use the TwitterBar Section.